xylyx

Drug response changes in the presence of ECM. Evaluate drug candidates in disease-relevant ECM settings IN MATRICO® that yield more predictive, in vivo-like results.

Related Resources

Application Note: Accelerating Antifibrotic Drug Development with Human Fibrotic Liver ECM Substrates
Application Note: Accelerating Antifibrotic Drug Development with Human Fibrotic Lung ECM Substrates
Application Note: IN SITE™ Metastasis Kit to Accelerate Anticancer Drug Development
Publication: Fibrotic Human Lung Extracellular Matrix as a Disease-Specific Substrate for Models of Pulmonary Fibrosis (2019)
Poster: Fibrotic Liver Extracellular Matrix Substrates for 3D in-vitro Models of Human Liver Fibrosis
Poster: Fibrotic Lung Extracellular Matrix Substrates for 3D in-vitro Models of Human Pulmonary Fibrosis
Poster: TissueSpec® Bone, Liver, and Lung ECM Substrates Enable Disease-Relevant in-vitro Models of Pre-Metastatic Tissue Microenvironments
Poster: TissueSpec® ECM Hydrogels for Predictive 3D Models of Human Cancer
Webinar: Redefining Cancer Research with IN SITE™ Metastasis Kit
Webinar: Transforming Lung Fibrosis Drug Discovery with The IN MATRICO® Human Lung Fibrosis Platform